In-line Performance, Outlook Remains Positive: Revenue for Q3FY17 is at Rs. 1535 Mn as against Rs. 1447 Mn in Q3FY16,marked 6.1% growth YoY basis. During the quarter, revenue surged due to strong performance of Inorganic fluorides and CRAM business unit which have grown by22.8% & 26.8% YoY, respectively. EBITDA stood at Rs. 301 Mn with the growth at 33.5% YoY and the margins stood at 19.6% gaining 402 bps YoY mainly due to better product mix which led to increase in volume during aforesaid period. PAT came at Rs. 206 Mn in Q3FY17 compared to Rs. 136 Mn in Q3FY16 registering the growth of 51.5% YoY.